KIC
RMD icon

Keating Investment Counselors’s ResMed RMD Stock Holding History

Keating Investment Counselors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,655
Closed -$285K – 87
2023
Q4 		$285K Hold
1,655
– – 0.1% 77
2023
Q3 		$245K Hold
1,655
– – 0.08% 79
2023
Q2 		$362K Sell
1,655
-600
-27% -$134K 0.13% 66
2023
Q1 		$494K Sell
2,255
-625
-22% -$136K 0.19% 58
2022
Q4 		$599K Buy
+2,880
New +$633K 0.23% 59

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Keating Investment Counselors's RMD Position: Q1 2024 in Review

Keating Investment Counselors sold out of ResMed (RMD) in Q1 2024, closing a stake of 1,655 shares — an estimated $285K sold.

Keating Investment Counselors first reported a position in RMD in Q4 2022 and held it in 5 quarters. The position peaked at $599K in Q4 2022. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Keating Investment Counselors reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Keating Investment Counselors sold 1,655 ResMed shares in Q1 2024, an estimated $285K.
  • Keating Investment Counselors first reported a position in ResMed in Q4 2022 and held it in 5 quarters.
  • Keating Investment Counselors's ResMed position peaked at $599K in Q4 2022.
  • 718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Keating Investment Counselors's 13F filing for Q1 2024, filed 7 May 2024.